Response to ASX Query Letter
Filed with ASX · · 5 pages · English
Earlier from Argent Biopharma
- AMC inc. places US$3M CimetrA purchase order
- First order received under US supply agreement
- ArtemiC eu sale approval and clinical trial update
- UK import permit granted for CannEpil
- Cimetra import approval granted for india
Later from Argent Biopharma
- Cimetra dose finding study approval
- Malta cimetra production facility update
- US Supply and Distribution Agreement Update
- Production Completed of A$1M ArtemiC Order from SPC
- UK Capital Raising Completed
Follow Argent Biopharma into a list and get an email when it puts out news.
Follow Argent Biopharma